• Dual-Action Kinase Inhibitors Accelerate p38α MAPK Dephospho

  2026-07-21

  The referenced study reveals that certain kinase inhibitors, including those targeting p38α MAPK, can simultaneously block kinase activity and promote dephosphorylation by stabilizing specific inactive conformations. This dual-action mechanism suggests a new strategy for designing highly selective inhibitors with improved potency, which is relevant for inflammation, neurodegeneration, and type 1 diabetes research.

• GPR35-KLF5 Circuitry Orchestrates Epithelial Repair in DSS C

  2026-07-21

  This study uncovers a tryptophan metabolism-sensing mechanism in intestinal epithelial cells, where GPR35 detects mucosal damage and activates KLF5-driven repair via the PI3K-AKT-mTOR pathway. These findings refine our understanding of ulcerative colitis pathogenesis and suggest new targets for therapeutic intervention.

• Nicotinamide Adenine Dinucleotide (NAD+): Enhancing Metaboli

  2026-07-20

  Harness the power of Nicotinamide Adenine Dinucleotide (NAD+) for advanced metabolic signaling, autophagy, and enzyme activity research. Learn how APExBIO’s high-purity NAD+ drives reproducible workflows and enables troubleshooting, guided by the latest mechanistic insights into AMPK and energy stress.

• Sodium Phosphate Dibasic in Biochemical Assay Buffers: Appli

  2026-07-20

  Sodium phosphate dibasic (Na2HPO4) stands apart as a pH stabilizer and buffer for biological assays, enabling reproducible results in aquatic toxicology, protein quantification, and enzyme kinetics. This article translates recent research and best practices into actionable protocols, workflow optimizations, and troubleshooting insights for scientists leveraging APExBIO’s high-purity product.

• Patient-Derived Gastric Cancer Assembloids Reveal Stromal Im

  2026-07-19

  This study establishes a patient-derived gastric cancer assembloid model that integrates matched tumor organoids with autologous stromal cell subpopulations, providing a physiologically relevant platform to explore drug sensitivity and resistance. The approach enables detailed analysis of tumor–stroma interactions and supports individualized therapeutic screening.

• Lysosomal β-Galactosidase Controls in Translational Senescen

  2026-07-18

  This article explores the emerging mechanistic links between SLC25A1-driven cellular senescence and cisplatin resistance in head and neck squamous cell carcinoma (HNSCC), and provides strategic guidance for translational researchers on the robust application of lysosomal β-galactosidase staining as an assay control. Incorporating insights from recent studies and the latest product innovations, it details how the APExBIO Lysosomal β-Galactosidase Staining Kit (K2181) elevates assay reliability, addresses artifacts, and supports next-generation translational workflows.

• Bufuralol Hydrochloride: Precision Tools for β-Adrenergic Re

  2026-07-17

  Explore Bufuralol hydrochloride as a non-selective β-adrenergic receptor antagonist for advanced cardiovascular pharmacology research. This article uniquely dissects assay design, mechanistic nuances, and practical integration with organoid models.

• Fenofibrate Induces Liver Enlargement via PPARα-YAP in Aging

  2026-07-17

  This study demonstrates that Fenofibrate-induced liver enlargement and activation of PPARα-YAP signaling occur to a similar extent in both adult and aging mice, indicating these effects are independent of age. These findings refine our understanding of PPARα agonist actions in hepatic physiology and have implications for the use of Fenofibrate in metabolic and cancer research models involving aged subjects.

• Aurora Kinase A Overexpression in Retinoblastoma: Implicatio

  2026-07-16

  This study demonstrates that Aurora kinase A (AURKA) is consistently overexpressed in human retinoblastoma and closely correlates with histopathological high-risk factors and poor chemotherapy response. These findings provide a strong rationale for targeting AURKA as a therapeutic strategy, especially in advanced or refractory retinoblastoma cases.

• HotStart Universal 2X Green qPCR Master Mix: Precision for I

  2026-07-16

  Unlock reproducible, high-specificity gene expression quantification in complex immune profiling studies with HotStart™ Universal 2X Green qPCR Master Mix. Its robust hot-start Taq polymerase and advanced dye formulation empower researchers to confidently dissect disease models and troubleshoot challenging workflows.

• Lysosomal β-Galactosidase Staining Kit: Reliable Senescence

  2026-07-15

  This article addresses real-world challenges in cell senescence staining and control assay reproducibility, focusing on the Lysosomal β-Galactosidase Staining Kit (SKU K2181). Using scenario-driven Q&As, it demonstrates how this kit delivers precise, artifact-free results, workflow compatibility, and evidence-backed differentiation for biomedical researchers.

• Dextran Sulfate Sodium Salt in Mouse Colitis Models: Protoco

  2026-07-15

  Dextran sulfate sodium salt (MW 35000-45000) is the gold standard for inducing colitis-like intestinal inflammation in mice, enabling high-fidelity modeling of ulcerative colitis pathogenesis and mucosal repair. This article delivers actionable workflows, troubleshooting tips, and translational insights grounded in recent molecular discoveries for researchers seeking robust, reproducible IBD models.

• Unveiling Cathepsin B Inhibitor CA-074: Mechanistic Insights

  2026-07-14

  Discover how Cathepsin B inhibitor CA-074 enables advanced disease modeling through its selective mechanism, high-affinity inhibition, and translational relevance. Learn what recent mechanistic breakthroughs mean for cancer and neurodegeneration research.

• Dextran Sulfate Sodium Salt (MW 35000-45000): Innovations in

  2026-07-14

  Explore how Dextran sulfate sodium salt (MW 35000-45000) advances mouse models of inflammatory bowel disease by precisely inducing mucosal barrier dysfunction. This article uniquely bridges molecular insights with practical protocol guidance for targeted ulcerative colitis research.

• Carbenoxolone disodium: Protocols for 11β-HSD Inhibition Stu

  2026-07-13

  Carbenoxolone disodium is a potent 11β-hydroxysteroid dehydrogenase inhibitor and gap junction communication blocker, used to dissect glucocorticoid signaling and cell-to-cell communication in tissue models. It is not suited for in vivo efficacy studies or experiments where off-target effects cannot be controlled. Researchers should adhere to established product specifications and workflow best practices for assay reliability.

14817 records 1/988 page Next 12345 下5页 Last page